MLchartDataset catalogue

Site specific immunomodulator QBECO

Term · Oncology and biomedicine · MLC-T-ONC-016766

A formulation composed of components of the inactivated bacteria Escherichia coli (E. coli), with potential immunomodulating activity. Upon subcutaneous administration, site specific immunomodulator (SSI) QBECO stimulates the innate immune system by recruiting and activating M1 macrophages. This may restore the unhealthy and altered gut microbiome, restore the function in the gastrointestinal (GI) tact, restore the immune system and rebuild normal barrier function. In addition, by enhancing and optimizing immune function, cancer cell proliferation may be inhibited and GI tract-related inflammatory diseases may be treated.

Table 1. Record
IdentifierMLC-T-ONC-016766
FieldOncology and biomedicine
SynonymsSSI QBECO; E. coli-based formulation QBECO
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-016766",
  "term": "Site specific immunomodulator QBECO",
  "field": "Oncology and biomedicine",
  "definition": "A formulation composed of components of the inactivated bacteria Escherichia coli (E. coli), with potential immunomodulating activity. Upon subcutaneous administration, site specific immunomodulator (SSI) QBECO stimulates the innate immune system by recruiting and activating M1 macrophages. This may restore the unhealthy and altered gut microbiome, restore the function in the gastrointestinal (GI) tact, restore the immune system and rebuild normal barrier function. In addition, by enhancing and optimizing immune function, cancer cell proliferation may be inhibited and GI tract-related inflammatory diseases may be treated.",
  "synonyms": [
    "SSI QBECO",
    "E. coli-based formulation QBECO"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/site-specific-immunomodulator-qbeco/"
}

Record 15,045 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.